Cancer-Causing Herbal Remedies

A potent carcinogen lurks within certain traditional Chinese medicines.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Member of the Aristolochia genusWIKIMEDIA, BOGDANPlants of the Aristolochia genus have for centuries been used in Chinese herbal remedies, but they contain a naturally carcinogenic compound that causes mutations in the cells of people who consume them, according to two studies published in Science Translational Medicine today (August 7). The papers reveal that the compound, called aristolochic acid, causes more mutations than two of the best-known environmental carcinogens: tobacco smoke and UV light.

“A lot of people in the lay public assume that if something is herbal or natural that it is necessarily healthy,” said Marc Ladanyi, an investigator in the human oncology and pathogenesis program at Memorial Sloan-Kettering Cancer Center in New York who was not involved in the studies. “But this work very clearly shows that this natural plant product is extremely genotoxic and carcinogenic.”

Despite the long history of Aristolochia use in herbal remedies, evidence of the plants’ inherent danger emerged only recently. In the early 1990s, women who had received Aristolochia treatments at a weight loss clinic in Belgium developed kidney problems that progressed to renal failure and, in later years, to abnormal growths in their upper urinary tracts. More recently, Aristolochia contamination of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies